A Phase II Randomized Double-Masked Trial of Pegaptanib, an Anti–Vascular Endothelial Growth Factor Aptamer, for Diabetic Macular Edema

Ophthalmology ◽  
2005 ◽  
Vol 112 (10) ◽  
pp. 1747-1757 ◽  
Keyword(s):  
Vascular Endothelial Growth Factor ◽  
Growth Factor ◽  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Phase Ii ◽  
Vascular Endothelial ◽  
Endothelial Growth Factor

scholarly journals Anti–Vascular Endothelial Growth Factor Comparative Effectiveness Trial for Diabetic Macular Edema

2016 ◽  
Vol 134 (12) ◽  
pp. 1429 ◽  
Author(s):  
Lee M. Jampol ◽  
Adam R. Glassman ◽  
Neil M. Bressler ◽  
John A. Wells ◽  
Allison R. Ayala ◽  
...  
Keyword(s):  
Vascular Endothelial Growth Factor ◽  
Growth Factor ◽  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Comparative Effectiveness ◽  
Effectiveness Trial ◽  
Vascular Endothelial ◽  
Endothelial Growth Factor

scholarly journals Visual Outcomes Based on Early Response to Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema

2018 ◽  
Vol 239 (2-3) ◽  
pp. 94-102 ◽  
Author(s):  
Yoshito Koyanagi ◽  
Shigeo Yoshida ◽  
Yoshiyuki Kobayashi ◽  
Yuki Kubo ◽  
Takahito Nakama ◽  
...  
Keyword(s):  
Vascular Endothelial Growth Factor ◽  
Growth Factor ◽  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Early Response ◽  
Vascular Endothelial ◽  
Visual Outcomes ◽  
Endothelial Growth Factor ◽  
Growth Factor Treatment
Sign in / Sign up

Export Citation Format

Share Document